Is fibrinolysis (breakdown of fibrin) done in all ST-elevation myocardial infarctions (STEMI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fibrinolysis in ST-Elevation Myocardial Infarction (STEMI)

Fibrinolysis is not performed in all ST-elevation myocardial infarctions (STEMI), but rather is reserved for specific clinical scenarios when primary percutaneous coronary intervention (PCI) cannot be performed in a timely manner. 1

Primary Reperfusion Strategy for STEMI

Primary PCI vs. Fibrinolysis

  • Primary PCI is the preferred reperfusion strategy for STEMI when it can be performed within 90 minutes of first medical contact 2
  • Fibrinolysis should be administered when primary PCI cannot be performed within 120 minutes of first medical contact 3
  • The mortality benefit of fibrinolysis is directly related to time from symptom onset, with maximum benefit achieved with earliest possible administration 1

Indications for Fibrinolysis in STEMI

Fibrinolytic therapy should be administered to STEMI patients when:

  • Symptom onset is within 12 hours 1
  • ST elevation >0.1 mV in at least 2 contiguous precordial leads or 2 adjacent limb leads 1
  • New or presumably new left bundle branch block (LBBB) 1
  • Primary PCI cannot be performed within the recommended timeframe 1

Contraindications to Fibrinolysis

Absolute contraindications include:

  • History of intracranial hemorrhage
  • Significant closed head or facial trauma within past 3 months
  • Uncontrolled hypertension
  • Ischemic stroke within past 3 months
  • Active bleeding or bleeding diathesis
  • Suspected aortic dissection 1, 2

Decision Algorithm for Reperfusion in STEMI

  1. First Medical Contact (FMC) Assessment:

    • Obtain 12-lead ECG within 10 minutes
    • Establish IV access
    • Administer aspirin 160-325 mg 2
  2. Reperfusion Decision:

    • If primary PCI available within 90-120 minutes → Choose primary PCI
    • If primary PCI not available within 120 minutes → Administer fibrinolysis within 30 minutes of FMC 3
    • If patient has contraindications to fibrinolysis → Transfer for primary PCI regardless of time delay 1
  3. Post-Fibrinolysis Management:

    • Monitor for reperfusion success
    • Consider rescue PCI for failed fibrinolysis (60-120 minutes after administration) 1
    • For successful fibrinolysis, consider early angiography within 24 hours 1

Current Practice Challenges

Despite guidelines recommending door-to-needle times ≤30 minutes for fibrinolysis, only 44.5% of patients receive fibrinolysis within this timeframe 4. Delays in fibrinolysis are associated with worse outcomes, including higher rates of death, shock, and stroke 4.

Special Considerations

  • Patients ≥75 years have higher risk of intracranial hemorrhage with fibrinolysis 1
  • Patients with high risk of intracranial hemorrhage (≥4%) should receive primary PCI rather than fibrinolysis 1
  • In areas where primary PCI facilities are unavailable, modern fibrinolytic strategies (immediate fibrinolysis followed by transfer for rescue or early PCI) remain essential 5

Common Pitfalls to Avoid

  1. Delaying fibrinolysis when primary PCI cannot be performed within the recommended timeframe
  2. Administering fibrinolysis when contraindicated (especially in patients with history of intracranial bleeding)
  3. Failing to recognize failed fibrinolysis and delaying rescue PCI
  4. Not transferring patients to PCI-capable centers after fibrinolysis for potential early angiography
  5. Using fibrinolysis in patients with only ST-segment depression (unless posterior MI is suspected) 1

The decision between primary PCI and fibrinolysis should be based on time from symptom onset, anticipated delays to primary PCI, contraindications to fibrinolysis, and available healthcare resources. While primary PCI is preferred when available in a timely manner, fibrinolysis remains a critical reperfusion strategy for many STEMI patients worldwide.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Arrhythmia and Myocardial Infarction Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Timely and optimal treatment of patients with STEMI.

Nature reviews. Cardiology, 2013

Research

Is There Still a Role for Fibrinolysis in ST-Elevation Myocardial Infarction?

Current treatment options in cardiovascular medicine, 2013

Related Questions

What is the treatment for acute ST-Elevation Myocardial Infarction (STEMI)?
What are the considerations for fibrinolytic therapy in an elderly male with ST-Elevation Myocardial Infarction (STEMI) and ongoing chest pain 24 hours post-onset, where Percutaneous Coronary Intervention (PCI) is not available?
What is the recommended management for STEMI (ST-Elevation Myocardial Infarction) patients with multivessel disease when PCI (Percutaneous Coronary Intervention) is not immediately feasible, according to the ESC (European Society of Cardiology) ACS (Acute Coronary Syndrome) guideline 2023?
What is the current recommendation for STEMI (ST-Elevation Myocardial Infarction) patients with multivessel disease when PCI (Percutaneous Coronary Intervention) is not immediately feasible due to lack of facility?
Is fibrinolysis (breakdown of fibrin) done in Non-ST-Elevation Myocardial Infarction (NSTEMI)?
Why does tenecteplase (tissue plasminogen activator) cause intracranial hemorrhage?
What is the ideal time frame for administering streptokinase in ST-elevation myocardial infarction (STEMI)?
What is the pathophysiology of dengue?
What is the management for a 40-year-old female with a 12-year history of varicose veins (varicosities), presenting with left limb edema and heaviness when standing, intact distal pulses, and bilateral varicose veins in the great saphenous vein territory?
What is Arimidex (anastrozole) used for?
What are early and late pathologies in achalasia evaluation, based on the type of achalasia (Lower Esophageal Sphincter - LES) disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.